Thorbjørn Terndrup Nielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thorbjørn Terndrup Nielsen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Catherine Amiel
Université Paris Est, ICMPE (UMR7182), CNRS, UPEC, F 94320, Thiais, France
2 shared publications- Kim Lambertsen Larsen
Department of Chemistry and Bioscience, Section of Chemistry, Aalborg University, Aalborg, Denmark
2 shared publications - Lars Wagner Städe
Aalborg Univ, Dept Chem & Biosci, Frederik Bajers Vej 7H, DK-9220 Aalborg, Denmark
2 shared publications Reinhard Wimmer
Department of Chemistry and Bioscience, Aalborg University, Fredrik Bajers Vej 7H, 9220 Aalborg, Denmark
2 shared publicationsVéronique Wintgens
Université Paris Est, ICMPE (UMR7182), CNRS, UPEC, F 94320, Thiais, France
2 shared publications- Alex Fragoso
Departament d’Enginyeria Quimica, Universitat Rovira i Virgili, 43007 Tarragona, Spain
1 shared publication
Latest Publications
- Open Access
- 17 April 2024
- Published by Elsevier in Carbohydrate Polymers
- Vol. 338, 122167
Solving the puzzle of 2-hydroxypropyl β-cyclodextrin: Detailed assignment of the substituent distribution by NMR spectroscopy
- 17 April 2024
- Published by Elsevier in Carbohydrate Polymers
- Vol. 338, 122167
Open AccessSolving the puzzle of 2-hydroxypropyl β-cyclodextrin: Detailed assignment of the substituent distribution by NMR spectroscopy
- Open Access
- 9 March 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (3) , 598
Supramolecular Complexes of Plant Neurotoxin Veratridine with Cyclodextrins and Their Antidote-like Effect on Neuro-2a Cell Viability
Veratridine (VTD) is a plant neurotoxin that acts by blocking the voltage-gated sodium channels (VGSC) of cell membranes. Symptoms of VTD intoxication include intense nausea, hypotension, arrhythmia, and loss of consciousness. The treatment for the intoxication is mainly focused on treating the symptoms, meaning there is no specific antidote against VTD. In this pursuit, we were interested in studying the molecular interactions of VTD with cyclodextrins (CDs). CDs are supramolecular macrocycles with the ability to form host–guest inclusion complexes (ICs) inside their hydrophobic cavity. Since VTD is a lipid-soluble alkaloid, we hypothesized that it could form stable inclusion complexes with different types of CDs, resulting in changes to its physicochemical properties. In this investigation, we studied the interaction of VTD with β-CD, γ-CD and sulfobutyl ether β-CD (SBCD) by isothermal titration calorimetry (ITC) and nuclear magnetic resonance (NMR) spectroscopy. Docking and molecular dynamics studies confirmed the most stable configuration for the inclusion complexes. Finally, with an interest in understanding the effects of the VTD/CD molecular interactions, we performed cell-based assays (CBAs) on Neuro-2a cells. Our findings reveal that the use of different amounts of CDs has an antidote-like concentration-dependent effect on the cells, significantly increasing cell viability and thus opening opportunities for novel research on applications of CDs and VTD.
- 9 March 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (3) , 598
Open AccessSupramolecular Complexes of Plant Neurotoxin Veratridine with Cyclodextrins and Their Antidote-like Effect on Neuro-2a Cell Viability
Veratridine (VTD) is a plant neurotoxin that acts by blocking the voltage-gated sodium channels (VGSC) of cell membranes. Symptoms of VTD intoxication include intense nausea, hypotension, arrhythmia, and loss of consciousness. The treatment for the intoxication is mainly focused on treating the symptoms, meaning there is no specific antidote against VTD. In this pursuit, we were interested in studying the molecular interactions of VTD with cyclodextrins (CDs). CDs are supramolecular macrocycles with the ability to form host–guest inclusion complexes (ICs) inside their hydrophobic cavity. Since VTD is a lipid-soluble alkaloid, we hypothesized that it could form stable inclusion complexes with different types of CDs, resulting in changes to its physicochemical properties. In this investigation, we studied the interaction of VTD with β-CD, γ-CD and sulfobutyl ether β-CD (SBCD) by isothermal titration calorimetry (ITC) and nuclear magnetic resonance (NMR) spectroscopy. Docking and molecular dynamics studies confirmed the most stable configuration for the inclusion complexes. Finally, with an interest in understanding the effects of the VTD/CD molecular interactions, we performed cell-based assays (CBAs) on Neuro-2a cells. Our findings reveal that the use of different amounts of CDs has an antidote-like concentration-dependent effect on the cells, significantly increasing cell viability and thus opening opportunities for novel research on applications of CDs and VTD.
- 1 July 2019
- Published by Elsevier in European Polymer Journal
- Vol. 116, 84-90
Direct synthesis of well-defined zwitterionic cyclodextrin polymers via atom transfer radical polymerization
- 1 July 2019
- Published by Elsevier in European Polymer Journal
- Vol. 116, 84-90
Direct synthesis of well-defined zwitterionic cyclodextrin polymers via atom transfer radical polymerization
- 1 June 2019
- Published by Elsevier in Carbohydrate Polymers
- Vol. 213, 403-410
Self-assembled nanoparticles based on cyclodextrin-modified pullulan: Synthesis, and structural characterization using SAXS
- 1 June 2019
- Published by Elsevier in Carbohydrate Polymers
- Vol. 213, 403-410
Self-assembled nanoparticles based on cyclodextrin-modified pullulan: Synthesis, and structural characterization using SAXS
- 1 November 2015
- Published by Elsevier in Carbohydrate Polymers
- Vol. 133, 473-481
Bifunctionalized dextrans for surface PEGylation via multivalent host–guest interactions
- 1 November 2015
- Published by Elsevier in Carbohydrate Polymers
- Vol. 133, 473-481
Bifunctionalized dextrans for surface PEGylation via multivalent host–guest interactions
- Open Access
- 21 January 2015
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 11 (1) , 147-154
Formation of nanoparticles by cooperative inclusion between (S)-camptothecin-modified dextrans and β-cyclodextrin polymers
Novel (S)-camptothecin–dextran polymers were obtained by “click” grafting of azide-modified (S)-camptothecin and alkyne-modified dextrans. Two series based on 10 kDa and 70 kDa dextrans were prepared with a degree of substitution of (S)-camptothecin between 3.1 and 10.2%. The binding properties with β-cyclodextrin and β-cyclodextrin polymers were measured by isothermal titration calorimetry and fluorescence spectroscopy, showing no binding with β-cyclodextrin but high binding with β-cyclodextrin polymers. In aqueous solution nanoparticles were formed from association between the (S)-camptothecin–dextran polymers and the β-cyclodextrin polymers.
- 21 January 2015
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 11 (1) , 147-154
Open AccessFormation of nanoparticles by cooperative inclusion between (S)-camptothecin-modified dextrans and β-cyclodextrin polymers
Novel (S)-camptothecin–dextran polymers were obtained by “click” grafting of azide-modified (S)-camptothecin and alkyne-modified dextrans. Two series based on 10 kDa and 70 kDa dextrans were prepared with a degree of substitution of (S)-camptothecin between 3.1 and 10.2%. The binding properties with β-cyclodextrin and β-cyclodextrin polymers were measured by isothermal titration calorimetry and fluorescence spectroscopy, showing no binding with β-cyclodextrin but high binding with β-cyclodextrin polymers. In aqueous solution nanoparticles were formed from association between the (S)-camptothecin–dextran polymers and the β-cyclodextrin polymers.
- 1 July 2014
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 468 (1-2) , 258-263
β-Cyclodextrin-dextran polymers for the solubilization of poorly soluble drugs
- 1 July 2014
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 468 (1-2) , 258-263
β-Cyclodextrin-dextran polymers for the solubilization of poorly soluble drugs